Faculty profile

Cynthia Gagnon

ResearcherUniversité du Québec à Chicoutimi

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université du Québec à Chicoutimi directory, so their courses and email address may be missing. Find their university profile.

Cynthia Gagnon

Researcher

Health Sciences

Université du Québec à Chicoutimi

Saguenay, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
53 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Autosomal Recessive Spastic Ataxia Of Charlevoix-Saguenay Balance Exercise Program Hereditary Spastic Paraplegia Mobility Motor Control Movement Disorders Neurology

Latest papers

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.
Muscle & nerve · 2026 · senior author
Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.
Journal of women's health (2002) · 2026 · first author
Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.
Journal of neuromuscular diseases · 2026

All 95 publications

Latest funding

IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial
CIHR · 2022 · Principal investigator
$638,776

All 1 grants and awards

95 publications.

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.

Bélair N, Brisson JD, Brais B, Rodrigue X, Lochmüller H, Hébert LJ, MacGregor J, Dennison B, Lessard I, Côté I, Duchesne E, Gagnon C

Muscle & nerve2026Senior author

DOI: 10.1002/mus.70343 PMID: 42439050

Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.

Gagnon C, Savard C, Fisette-Paulhus I, Tamizi A, Tremblay A, Lavoie M, Morin M

Journal of women's health (2002)2026First author

DOI: 10.1177/15409996261454984 PMID: 42272165

Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.

Osman H, Masnata M, Adamji Z, Rodrigue X, Nguyen CÉ, Slayter J, Beattie E, Lintern S, Lochmuller H, O'Connell C, Gagnon C, Warman-Chardon J

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602261416298 PMID: 41564276

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

van As D, Claeys T, Salz R, Haver DV, Dufour S, Deelen AV, Gloerich J, Gabriels R, Volders PJ, Dobelmann V, Gangfuss A, Ruck T, Gourdon G, Duchesne E, Gagnon C, Roos A, Gool AV, Impens F, Martens L, Lochmüller H, Schoser B, Bassez G, van Engelen BG, 't Hoen PA, OPTIMISTIC consortium, ReCognitION consortium

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602251410443 PMID: 41544176

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Sansone VA, Lizio A, Ferrari Aggradi CR, Greco LC, Gagnon C, Subramony S, Roxburgh RH, Mul K, Hamel J, Eichinger K, Hung M, Statland JM, Turner C, Elsheikh B, Schoser B, Ragole T, Matthews E, Sampson J, Takahashi MP, Wicklund M, Swenson A, Laverty CG, Shieh P, Greene EP, Beretta M, Casiraghi JL, Dekdebrun J, Raymond J, Langeslay R, DeSpain E, Thornton CA, Heatwole C, Johnson NE, Myotonic Dystrophy Clinical Research Network

Muscle & nerve2026

DOI: 10.1002/mus.70277 PMID: 42115131

What is known about muscle weakness, balance impairments and indoor mobility limitations in oculopharyngeal muscular dystrophy? A scoping review.

Bélair N, Gagnon C, Duchesne E

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602251397052 PMID: 41467981

Exploring the impact of myotonia on daily functioning in myotonic dystrophy: a patient-reported survey.

Sansone VA, Dang UJ, Edmondson L, Díaz-Manera J, Nikolenko N, Ashley EJ, Bassez G, Gagnon C, Montagnese F, Osman H, Tard C, Nowak U, Turner C, Zozulya-Weidenfeller A

BMC neurology2026

DOI: 10.1186/s12883-026-05002-4 PMID: 42298468

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study.

Fortin J, Gaudet I, Côté I, Gagnon C, Gallais B

BMC neurology2026

DOI: 10.1186/s12883-026-04816-6 PMID: 42050457

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Fortin J, Synofzik M, Pedneault-Tremblay ÉA, Hermle D, Thieme A, Timmann D, La Piana R, Brais B, Dolbec J, Côté I, Gagnon C, Traschütz A

Movement disorders : official journal of the Movement Disorder Society2026

DOI: 10.1002/mds.70201 PMID: 41669957

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Mul K, Eichinger K, Hung M, Sansone VA, Gagnon C, Subramony S, Roxburgh RH, Hamel J, Statland JM, Elsheikh B, Turner C, Sampson J, Ragole T, Matthews E, Schoser B, Swenson A, Laverty C, Shieh P, Greene EP, Takahashi M, Wicklund M, Dekdebrun J, Raymond J, DeSpain E, Thornton CA, Johnson NE, Myotonic Dystrophy Clinical Research Network

PloS one2025

DOI: 10.1371/journal.pone.0331163 PMID: 41379803

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Autosomal Recessive Spastic Ataxia Of Charlevoix-Saguenay Dear Professor Gagnon, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Cynthia Gagnon

Research

Latest papers

Latest funding

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.

Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.

Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

What is known about muscle weakness, balance impairments and indoor mobility limitations in oculopharyngeal muscular dystrophy? A scoping review.

Exploring the impact of myotonia on daily functioning in myotonic dystrophy: a patient-reported survey.

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study.

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial

Frequent collaborators

Cynthia Gagnon

Bernard Brais

Elise Duchesne

Elise Duchesne

Luigi Bouchard

Luigi Bouchard

Bernard Brais

Bernard Brais

Homira Osman

Krista Best

Roberta La Piana

Aymeric Ravel-Chapuis

Rosanna Weksberg

Hanns Lochmüller

Reshma Amin

Jodi Warman Chardon

Gregor Andelfinger

Susan Cadell

David Chitayat

Maryam Oskoui

Serge McGraw